➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Merck
Johnson and Johnson
Express Scripts
Baxter

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

DIDANOSINE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for DIDANOSINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chang Gung Memorial HospitalPhase 1
TTY BiopharmPhase 1
Intergroupe Francophone de Cancerologie ThoraciquePhase 2

See all DIDANOSINE clinical trials

Medical Subject Heading (MeSH) Categories for DIDANOSINE
Paragraph IV (Patent) Challenges for DIDANOSINE
Tradename Dosage Ingredient NDA Submissiondate
VIDEX FOR SOLUTION;ORAL didanosine 020155 2011-06-06
VIDEX EC CAPSULE, DELAYED REL PELLETS;ORAL didanosine 021183 2004-06-01

US Patents and Regulatory Information for DIDANOSINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo DIDANOSINE didanosine TABLET, FOR SUSPENSION;ORAL 077275-001 Aug 14, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo DIDANOSINE didanosine TABLET, FOR SUSPENSION;ORAL 077275-003 Aug 14, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma DIDANOSINE didanosine FOR SOLUTION;ORAL 078112-001 Mar 8, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
Barr DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 077167-002 Dec 3, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-002 Oct 9, 1991 DISCN Yes No   Start Trial   Start Trial   Start Trial
Barr DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 077167-001 Dec 3, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma DIDANOSINE didanosine CAPSULE, DELAYED REL PELLETS;ORAL 090094-001 Sep 24, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DIDANOSINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020155-004 Oct 9, 1991   Start Trial   Start Trial
Bristol Myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020155-004 Oct 9, 1991   Start Trial   Start Trial
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-004 Oct 9, 1991   Start Trial   Start Trial
Bristol Myers Squibb VIDEX EC didanosine CAPSULE, DELAYED REL PELLETS;ORAL 021183-003 Oct 31, 2000   Start Trial   Start Trial
Bristol-myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020156-001 Oct 9, 1991   Start Trial   Start Trial
Bristol Myers Squibb VIDEX didanosine TABLET, CHEWABLE;ORAL 020154-002 Oct 9, 1991   Start Trial   Start Trial
Bristol Myers Squibb VIDEX EC didanosine CAPSULE, DELAYED REL PELLETS;ORAL 021183-001 Oct 31, 2000   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKinsey
McKesson
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.